Shrimps Disease Diagnostic Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: S3D324F5443AEN
Market Monitor Global

Abstracts

Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.

This report contains market size and forecasts of Shrimps Disease Diagnostic in Global, including the following market information:

Global Shrimps Disease Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Shrimps Disease Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

WSSV (White Spot Syndrome Virus) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Shrimps Disease Diagnostic include HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD, GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, AquaBounty Technologies, Inc and pop bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Shrimps Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Shrimps Disease Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Shrimps Disease Diagnostic Market Segment Percentages, by Type, 2021 (%)

• WSSV (White Spot Syndrome Virus)
• TSV (Taura Syndrome Virus)
• YHV/GAV (Yellow Head/Gill Associated Virus)
• IHHNV (Infectious Hypodermal and Hematopoietic Virus)
• HPV (Hepatopancreatic Parvovirus)
• MBV (Monodon Baculovirus)
• IMNV (Infectious Myonecrosis Virus)
• NHP-B (Necrotising Hepatopancreatitis Bacteria)
• MoV (Mourilyan Virus)
• Early Mortality Syndrome (EMS)

Global Shrimps Disease Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Shrimps Disease Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Fisheries
• Aquaculture Laboratories
• Marine Laboratories
• Education and Research Institutes
• Others

Global Shrimps Disease Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Shrimps Disease Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Shrimps Disease Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Shrimps Disease Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• HiMedia Laboratories
• Speedy Assay Sdn Bhd
• REAGEN LLC
• FUJIKURA KASEI CO., LTD
• GeneReach Biotechnology Corp
• Thermo Fisher Scientific
• Lab - Ind Resource Sdn Bhd
• AquaBounty Technologies, Inc
• pop bio
• SUREBIO
• Auro Biotechnologies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Shrimps Disease Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Shrimps Disease Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SHRIMPS DISEASE DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Shrimps Disease Diagnostic Market Size: 2021 VS 2028
2.2 Global Shrimps Disease Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Shrimps Disease Diagnostic Players in Global Market
3.2 Top Global Shrimps Disease Diagnostic Companies Ranked by Revenue
3.3 Global Shrimps Disease Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Shrimps Disease Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Shrimps Disease Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Shrimps Disease Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Shrimps Disease Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Shrimps Disease Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Shrimps Disease Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 WSSV (White Spot Syndrome Virus)
  4.1.3 TSV (Taura Syndrome Virus)
  4.1.4 YHV/GAV (Yellow Head/Gill Associated Virus)
  4.1.5 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
  4.1.6 HPV (Hepatopancreatic Parvovirus)
  4.1.7 MBV (Monodon Baculovirus)
  4.1.8 IMNV (Infectious Myonecrosis Virus)
  4.1.9 NHP-B (Necrotising Hepatopancreatitis Bacteria)
  4.1.10 MoV (Mourilyan Virus)
  4.1.11 Early Mortality Syndrome (EMS)
4.2 By Type - Global Shrimps Disease Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Shrimps Disease Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Shrimps Disease Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Shrimps Disease Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Shrimps Disease Diagnostic Market Size, 2021 & 2028
  5.1.2 Fisheries
  5.1.3 Aquaculture Laboratories
  5.1.4 Marine Laboratories
  5.1.5 Education and Research Institutes
  5.1.6 Others
5.2 By Application - Global Shrimps Disease Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Shrimps Disease Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Shrimps Disease Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Shrimps Disease Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Shrimps Disease Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Shrimps Disease Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Shrimps Disease Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Shrimps Disease Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Shrimps Disease Diagnostic Revenue, 2017-2028
  6.3.2 US Shrimps Disease Diagnostic Market Size, 2017-2028
  6.3.3 Canada Shrimps Disease Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Shrimps Disease Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Shrimps Disease Diagnostic Revenue, 2017-2028
  6.4.2 Germany Shrimps Disease Diagnostic Market Size, 2017-2028
  6.4.3 France Shrimps Disease Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Shrimps Disease Diagnostic Market Size, 2017-2028
  6.4.5 Italy Shrimps Disease Diagnostic Market Size, 2017-2028
  6.4.6 Russia Shrimps Disease Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Shrimps Disease Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Shrimps Disease Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Shrimps Disease Diagnostic Revenue, 2017-2028
  6.5.2 China Shrimps Disease Diagnostic Market Size, 2017-2028
  6.5.3 Japan Shrimps Disease Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Shrimps Disease Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Shrimps Disease Diagnostic Market Size, 2017-2028
  6.5.6 India Shrimps Disease Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Shrimps Disease Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Shrimps Disease Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Shrimps Disease Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Shrimps Disease Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Shrimps Disease Diagnostic Market Size, 2017-2028
  6.7.3 Israel Shrimps Disease Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Shrimps Disease Diagnostic Market Size, 2017-2028
  6.7.5 UAE Shrimps Disease Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 HiMedia Laboratories
  7.1.1 HiMedia Laboratories Corporate Summary
  7.1.2 HiMedia Laboratories Business Overview
  7.1.3 HiMedia Laboratories Shrimps Disease Diagnostic Major Product Offerings
  7.1.4 HiMedia Laboratories Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 HiMedia Laboratories Key News
7.2 Speedy Assay Sdn Bhd
  7.2.1 Speedy Assay Sdn Bhd Corporate Summary
  7.2.2 Speedy Assay Sdn Bhd Business Overview
  7.2.3 Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Major Product Offerings
  7.2.4 Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Speedy Assay Sdn Bhd Key News
7.3 REAGEN LLC
  7.3.1 REAGEN LLC Corporate Summary
  7.3.2 REAGEN LLC Business Overview
  7.3.3 REAGEN LLC Shrimps Disease Diagnostic Major Product Offerings
  7.3.4 REAGEN LLC Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 REAGEN LLC Key News
7.4 FUJIKURA KASEI CO., LTD
  7.4.1 FUJIKURA KASEI CO., LTD Corporate Summary
  7.4.2 FUJIKURA KASEI CO., LTD Business Overview
  7.4.3 FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Major Product Offerings
  7.4.4 FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 FUJIKURA KASEI CO., LTD Key News
7.5 GeneReach Biotechnology Corp
  7.5.1 GeneReach Biotechnology Corp Corporate Summary
  7.5.2 GeneReach Biotechnology Corp Business Overview
  7.5.3 GeneReach Biotechnology Corp Shrimps Disease Diagnostic Major Product Offerings
  7.5.4 GeneReach Biotechnology Corp Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 GeneReach Biotechnology Corp Key News
7.6 Thermo Fisher Scientific
  7.6.1 Thermo Fisher Scientific Corporate Summary
  7.6.2 Thermo Fisher Scientific Business Overview
  7.6.3 Thermo Fisher Scientific Shrimps Disease Diagnostic Major Product Offerings
  7.6.4 Thermo Fisher Scientific Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Thermo Fisher Scientific Key News
7.7 Lab - Ind Resource Sdn Bhd
  7.7.1 Lab - Ind Resource Sdn Bhd Corporate Summary
  7.7.2 Lab - Ind Resource Sdn Bhd Business Overview
  7.7.3 Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Major Product Offerings
  7.7.4 Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Lab - Ind Resource Sdn Bhd Key News
7.8 AquaBounty Technologies, Inc
  7.8.1 AquaBounty Technologies, Inc Corporate Summary
  7.8.2 AquaBounty Technologies, Inc Business Overview
  7.8.3 AquaBounty Technologies, Inc Shrimps Disease Diagnostic Major Product Offerings
  7.8.4 AquaBounty Technologies, Inc Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 AquaBounty Technologies, Inc Key News
7.9 pop bio
  7.9.1 pop bio Corporate Summary
  7.9.2 pop bio Business Overview
  7.9.3 pop bio Shrimps Disease Diagnostic Major Product Offerings
  7.9.4 pop bio Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 pop bio Key News
7.10 SUREBIO
  7.10.1 SUREBIO Corporate Summary
  7.10.2 SUREBIO Business Overview
  7.10.3 SUREBIO Shrimps Disease Diagnostic Major Product Offerings
  7.10.4 SUREBIO Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 SUREBIO Key News
7.11 Auro Biotechnologies
  7.11.1 Auro Biotechnologies Corporate Summary
  7.11.2 Auro Biotechnologies Business Overview
  7.11.3 Auro Biotechnologies Shrimps Disease Diagnostic Major Product Offerings
  7.11.4 Auro Biotechnologies Shrimps Disease Diagnostic Revenue in Global Market (2017-2022)
  7.11.5 Auro Biotechnologies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Shrimps Disease Diagnostic Market Opportunities & Trends in Global Market
Table 2. Shrimps Disease Diagnostic Market Drivers in Global Market
Table 3. Shrimps Disease Diagnostic Market Restraints in Global Market
Table 4. Key Players of Shrimps Disease Diagnostic in Global Market
Table 5. Top Shrimps Disease Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Shrimps Disease Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Shrimps Disease Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Shrimps Disease Diagnostic Product Type
Table 9. List of Global Tier 1 Shrimps Disease Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Shrimps Disease Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Shrimps Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Shrimps Disease Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Shrimps Disease Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Shrimps Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Shrimps Disease Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Shrimps Disease Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Shrimps Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Shrimps Disease Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Shrimps Disease Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Shrimps Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Shrimps Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Shrimps Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Shrimps Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Shrimps Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. HiMedia Laboratories Corporate Summary
Table 31. HiMedia Laboratories Shrimps Disease Diagnostic Product Offerings
Table 32. HiMedia Laboratories Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Speedy Assay Sdn Bhd Corporate Summary
Table 34. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Product Offerings
Table 35. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. REAGEN LLC Corporate Summary
Table 37. REAGEN LLC Shrimps Disease Diagnostic Product Offerings
Table 38. REAGEN LLC Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. FUJIKURA KASEI CO., LTD Corporate Summary
Table 40. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Product Offerings
Table 41. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. GeneReach Biotechnology Corp Corporate Summary
Table 43. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Product Offerings
Table 44. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Thermo Fisher Scientific Corporate Summary
Table 46. Thermo Fisher Scientific Shrimps Disease Diagnostic Product Offerings
Table 47. Thermo Fisher Scientific Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Lab - Ind Resource Sdn Bhd Corporate Summary
Table 49. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Product Offerings
Table 50. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. AquaBounty Technologies, Inc Corporate Summary
Table 52. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Product Offerings
Table 53. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. pop bio Corporate Summary
Table 55. pop bio Shrimps Disease Diagnostic Product Offerings
Table 56. pop bio Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. SUREBIO Corporate Summary
Table 58. SUREBIO Shrimps Disease Diagnostic Product Offerings
Table 59. SUREBIO Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Auro Biotechnologies Corporate Summary
Table 61. Auro Biotechnologies Shrimps Disease Diagnostic Product Offerings
Table 62. Auro Biotechnologies Shrimps Disease Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Shrimps Disease Diagnostic Segment by Type in 2021
Figure 2. Shrimps Disease Diagnostic Segment by Application in 2021
Figure 3. Global Shrimps Disease Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Shrimps Disease Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Shrimps Disease Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Shrimps Disease Diagnostic Revenue in 2021
Figure 8. By Type - Global Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Shrimps Disease Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Shrimps Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. HiMedia Laboratories Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. REAGEN LLC Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Thermo Fisher Scientific Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. pop bio Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. SUREBIO Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Auro Biotechnologies Shrimps Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)